Unsere Publikationen

Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs

Link
https://doi.org/10.3390/pathogens14030235
Tags
Multiple Sklerose
Jahr
2025
Autoren
Solchenberger H, Odendahl M, Schriefer D, Proschmann U, Rahbani GKa, Ziemssen T, Akgün K.
Verlag
Pathogens. 2025; 14(3):235.
Zum Eintrag

Patient Perspectives on Healthcare Utilization During the COVID-19 Pandemic in People with Multiple Sclerosis—A Longitudinal Analysis

Link
https://doi.org/10.3390/healthcare13060646
Tags
Multiple SkleroseMobilitätManagement & Science
Jahr
2025
Autoren
Stölzer-Hutsch H, Schriefer D, Kugler J, Ziemssen T.
Verlag
Healthcare. 2025; 13(6):646.
Zum Eintrag

Editorial: Digital twins in medicine—transition from theoretical concept to tool used in everyday care

Link
https://doi.org/10.3389/fdgth.2025.1573727
Tags
Multiple SkleroseMS BehandlungManagement & ScienceeHealth
Jahr
2025
Autoren
Gilbert S, Drummond D, Cotte F, Ziemssen T.
Verlag
Front Digit Health. 2025 Feb 27;7:1573727.
Zum Eintrag

Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study

Link
https://doi.org/10.1177/17562864241306575
Tags
Multiple SkleroseMS Behandlung
Jahr
2025
Autoren
Ziemssen T, Bass AD, Van Wijmeersch B, Eichau S, Richter S, Hoffmann F, Armstrong NM, Chirieac M, Cunha-Santos J, Singer BA.
Verlag
Ther Adv Neurol Disord. 2025 Feb 10;18:17562864241306575.
Zum Eintrag

Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS

Link
https://doi.org/10.1212/WNL.0000000000210142
Tags
Multiple SkleroseMS Behandlung
Jahr
2025
Autoren
Cerqueira JJ, Berthele A, Cree BAC, Filippi M, Pardo G, Pearson OR, Traboulsee A, Ziemssen T, Vollmer T, Bernasconi C, Mandel CR, Kulyk I, Chognot C, Raposo C, Schneble HM, Thanei GA, Incera E, Havrdová EK.
Verlag
Neurology. 2025 Feb 25;104(4):e210142.
Zum Eintrag

Digital Representation of Patients as Medical Digital Twins: Data-Centric Viewpoint

Link
https://doi.org/10.2196/53542
Tags
Multiple SkleroseManagement & ScienceeHealth
Jahr
2025
Autoren
Demuth S, De Sèze J, Edan G, Ziemssen T, Simon F, Gourraud PA.
Verlag
JMIR Med Inform. 2025 Jan 28;13:e53542.
Zum Eintrag

A plain language summary of a study exploring the experiences of people with relapsing–remitting multiple sclerosis: what symptoms and impacts of the disease matter most and how can they be evaluated better?

Link
https://doi.org/10.1080/17582024.2024.2441068
Tags
Multiple SkleroseMS Behandlung
Jahr
2025
Autoren
Barrett Amy, Olayinka-Amao O, Ziemssen T, Bharadia T, Henke C, Kamudoni P.
Verlag
Neurodegenerative Disease Management, January, 1–8.
Zum Eintrag

Cost–consequence analysis of early vs. delayed natalizumab use in highly active relapsing–remitting multiple sclerosis: a simulation study

Link
https://doi.org/10.1007/s00415-024-12723-4
Tags
Multiple SkleroseMS BehandlungManagement & ScienceGesundheitsökonomie
Jahr
2025
Autoren
Inojosa H, Schriefer D, Ness NH, Dillenseger A, Akgün K, Ziemssen T.
Verlag
J Neurol. 2025 Jan 17;272(2):153.
Zum Eintrag
1 2

Publikationen durchsuchen

Publikationen filtern

Filter
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Zeige alleVerstecke
Jahr
-